Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Myasthenia Gravis Clinical Trials
Myasthenia Gravis clinical trials are recruiting across 104 cities. Here are the cities with the most active studies:
Myasthenia Gravis Trial Phases
36 research organizations are sponsoring myasthenia gravis trials.
About Myasthenia Gravis
Myasthenia gravis is a chronic autoimmune neuromuscular disease that causes weakness in the skeletal muscles responsible for breathing and movement. It occurs when communication between nerves and muscles is disrupted. Treatment includes medications that improve neuromuscular transmission and immunosuppressive therapies.
Clinical trials are advancing new treatments for myasthenia gravis. Currently, 49 studies are recruiting a combined 21,081 participants across the United States. Research is being conducted by 36 organizations including Dana-Farber Cancer Institute, Myasthenia Gravis Foundation of America, ZS Associates and 33 others.
2026 Myasthenia Gravis Research Landscape
As of July 2026, the myasthenia gravis clinical trial landscape includes 49 actively recruiting studies across 104 cities in the United States. These studies are collectively seeking 21,081 participants, with an average enrollment target of 430 per study.
The research spans multiple phases of development: 17 studies are in PHASE3, 15 studies are in PHASE2, 6 studies are in PHASE1, 5 studies are in NA, 5 studies are in PHASE4. The presence of Phase 3 trials indicates that some myasthenia gravis treatments are in late-stage testing and may be approaching regulatory review.
Research is being led by 36 different organizations, including Dana-Farber Cancer Institute, Myasthenia Gravis Foundation of America, ZS Associates, Yale University, argenx, and 31 others. The large number of sponsors reflects significant research interest and investment in myasthenia gravis treatment advancement.
Geographically, myasthenia gravis trials are most concentrated in Boca Raton, Florida (12 trials); Orange, California (8 trials); Tampa, Florida (8 trials); Los Angeles, California (7 trials); Aurora, Colorado (7 trials) and 7 other cities.
Featured Myasthenia Gravis Studies
Highlighted recruiting studies for myasthenia gravis, selected by enrollment size and research scope.
Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome
Blood cancers occur when the molecules that control normal cell growth are damaged. Many of these changes can be detected by directly examining parts of the cancer or cells in blood. Several alterations that occur repeatedly in certain types of blood cancers have already been identified, and these discoveries have led to the development of new drugs that target those alterations. More remain to be...
Myasthenia Gravis Foundation of America Global MG Patient Registry
The goal of this observational study is to learn about the experiences of people living with Myasthenia Gravis (MG) in the United States. The main questions it aims to answer are: * How and when are people with MG diagnosed? * What are the most common symptoms associated with MG? * What treatments are being used to treat MG? * What are the impacts of MG on activities of daily living, employment a...
Validation and Scaling of Screening Program for Undiagnosed Myasthenia Gravis-Social Media Campaign Paired With a Self-moderated Assessment
This study expands and validates the pilot study NCT06381284. It is a fully remote, site-less, prospective, observational study enrolling adults in the United States (excluding U.S. territories) with undiagnosed neuromuscular symptoms. The primary objective is to determine the validity of a self-assessment tool in encouraging undiagnosed participants, recruited through a social media campaign, to ...
Frequently Asked Questions About Myasthenia Gravis Clinical Trials
Are there myasthenia gravis clinical trials near me?
Yes, there are 49 myasthenia gravis clinical trials currently recruiting across 104+ cities in the United States, including Boca Raton, Florida; Orange, California; Tampa, Florida. Browse the studies above to find one at a location convenient for you.
How do I join a myasthenia gravis clinical trial?
To join a myasthenia gravis clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are myasthenia gravis clinical trials free?
Yes, participation in myasthenia gravis clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of myasthenia gravis treatments are being studied?
Current myasthenia gravis clinical trials are testing a range of approaches across PHASE3 (17 studies), PHASE2 (15 studies), PHASE1 (6 studies), NA (5 studies), PHASE4 (5 studies). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 36 research organizations.
Is it safe to participate in myasthenia gravis clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 16, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 16, 2026 · Data from ClinicalTrials.gov